Syneos Health Reports Third Quarter 2021 Results
03 nov. 2021 06h16 HE
|
Syneos Health, Inc.
Highlights Third quarter revenue of $1,348.2 million increased 22.7% year-over-year.Clinical Solutions net new business awards of $1,353.8 million for the third quarter, representing year-over-year...
Syneos Health Reports Second Quarter 2021 Results
09 août 2021 06h12 HE
|
Syneos Health, Inc.
Highlights Second quarter revenue of $1,282.6 million, increased 6.1% sequentially and 26.6% year-over-year.Clinical Solutions net new business awards of $1,436.2 million for the second quarter,...
Syneos Health Communications Boosts Global Creative Capabilities with Renowned Talent
15 mars 2021 09h00 HE
|
Syneos Health, Inc.
MORRISVILLE, N.C., March 15, 2021 (GLOBE NEWSWIRE) -- Syneos Health Communications – the portfolio of Syneos Health® agencies designed to deliver insights-driven integrated communications spanning...
Syneos Health Helps Establish New Industry Standards Group to Improve Clinical Trial Collaboration and Execution
27 mars 2018 07h05 HE
|
Syneos Health
RALEIGH, N.C. , March 27, 2018 (GLOBE NEWSWIRE) -- Syneos Health™ (Nasdaq:SYNH), the only fully integrated biopharmaceutical solutions organization, today announced that the company is a founding...
INC Research/inVentiv Health Schedules Third Quarter 2017 Earnings Call for Thursday, November 9, 2017
19 oct. 2017 17h02 HE
|
INC Research, LLC
RALEIGH, N.C., Oct. 19, 2017 (GLOBE NEWSWIRE) -- INC Research/inVentiv Health (Nasdaq:INCR), the only fully-integrated biopharmaceutical solutions organization combining a CRO and CCO (Contract...
INC Research and inVentiv Health Announce Successful Completion of Merger
01 août 2017 09h12 HE
|
INC Research, LLC
Combination Creates the Only Fully Integrated Biopharmaceutical Solutions Organization with Combined Net Revenue of More Than $3 Billion Relaunch Under New Brand Planned for 2018 RALEIGH, N.C. and...
INC Research and inVentiv Health to Merge
10 mai 2017 06h03 HE
|
INC Research, LLC
Creates a Leading Global Biopharmaceutical Solutions Organization with Combined Net Revenue of More Than $3.2 Billion Combined Company Will Be Second Largest Biopharmaceutical Outsourcing Provider,...
INC Research is the First CRO to obtain IAOCR’s Silver Workforce Quality Accreditation Status
25 avr. 2017 10h00 HE
|
INC Research, LLC
RALEIGH, N.C., April 25, 2017 (GLOBE NEWSWIRE) -- INC Research Holdings, Inc. (Nasdaq:INCR), a leading global Phase I to IV contract research organization, and IAOCR, the accrediting organization...
INC Research Ranked “Top CRO to Work With” Among Top 10 Global CROs for Third Consecutive Time in Biannual CenterWatch Survey
03 avr. 2017 07h47 HE
|
INC Research, LLC
Survey ranking reinforces Company’s industry-leading position as CRO of Choice for sitesOnly company to rank consistently among top three CROs in every survey over the last decadeCompany rated a top...
INC Research Strengthens Real World & Late Phase and Global Consulting Capabilities with Key Leadership Appointments
30 mars 2017 12h51 HE
|
INC Research, LLC
Additional senior-level expertise enhances global CRO’s strategic services offering, helping large pharma to meet their commercial objectives while strongly positioning the Company to capitalize...